LGVN Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-04-11 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | 633,280 | P-Purchase | A | 42,553 | 2.35 | 100,000.00 |
| 2024-04-10 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | 590,727 | P-Purchase | A | 106,383 | 2.35 | 250,000.00 |
| 2024-04-10 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | 106,383 | P-Purchase | A | 106,383 | 2.35 | 250,000.00 |
| 2024-04-11 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | 42,553 | P-Purchase | A | 42,553 | 2.35 | 100,000.00 |
| 2024-04-11 | Hashad Mohamed Wa'el Ahmed | director, officer: Chief Executive Officer | 19,616 | P-Purchase | A | 10,638 | 2.35 | 24,999.00 |
| 2024-04-11 | Hashad Mohamed Wa'el Ahmed | director, officer: Chief Executive Officer | 10,638 | P-Purchase | A | 10,638 | 2.35 | 24,999.00 |
| 2024-04-11 | Soffer Rock | director | 208,534 | P-Purchase | A | 31,915 | 2.35 | 75,000.00 |
| 2024-04-10 | Soffer Rock | director | 176,619 | P-Purchase | A | 106,383 | 2.35 | 250,000.00 |
| 2024-04-10 | Soffer Rock | director | 106,383 | P-Purchase | A | 106,383 | 2.35 | 250,000.00 |
| 2024-04-11 | Soffer Rock | director | 31,915 | P-Purchase | A | 31,915 | 2.35 | 75,000.00 |
| 2024-03-12 | Hashad Mohamed Wa'el Ahmed | director, officer: Chief Executive Officer | 122,643 | A-Award | A | 80,200 | 0.00 | 0.00 |
| 2024-03-12 | Hashad Mohamed Wa'el Ahmed | director, officer: Chief Executive Officer | 89,777 | F-InKind | D | 32,866 | 0.54 | 17,748.00 |
| 2023-03-01 | Hashad Mohamed Wa'el Ahmed | officer: Chief Executive Officer | 50,000 | A-Award | A | 50,000 | 3.59 | 179,500.00 |
| 2024-01-02 | Locklear Lisa | officer: Chief Financial Officer | 36,824 | F-InKind | D | 4,098 | 1.32 | 5,409.00 |
| 2024-01-02 | Hashad Mohamed Wa'el Ahmed | director, officer: Chief Executive Officer | 42,443 | F-InKind | D | 5,123 | 1.32 | 6,762.00 |
| 2024-01-02 | Lehr Paul T | officer: General Counsel, Secretary | 142,406 | F-InKind | D | 992 | 1.32 | 1,309.00 |
| 2024-01-02 | Agafonova Nataliya | officer: Chief Medical Officer | 20,786 | F-InKind | D | 3,074 | 1.32 | 4,058.00 |
| 2024-01-10 | Ross Cathy | director | 10,000 | P-Purchase | A | 5,000 | 1.31 | 6,544.00 |
| 2023-12-29 | Baluch Khoso | director | 15,000 | P-Purchase | A | 8,322 | 1.43 | 11,915.00 |
| 2023-12-28 | Baluch Khoso | director | 6,678 | P-Purchase | A | 1,678 | 1.40 | 2,342.00 |
| 2023-12-28 | PFEFFER JEFFREY | director | 15,000 | P-Purchase | A | 10,000 | 1.35 | 13,500.00 |
| 2023-12-21 | LOSORDO DOUGLAS W | director | 12,000 | A-Award | A | 12,000 | 1.25 | 15,000.00 |
| 2023-12-21 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | 12,000 | A-Award | A | 12,000 | 1.25 | 15,000.00 |
| 2023-12-21 | Soffer Rock | director | 12,000 | A-Award | A | 12,000 | 1.25 | 15,000.00 |
| 2023-12-21 | Ungaro Ursula | director | 12,000 | A-Award | A | 12,000 | 1.25 | 15,000.00 |
| 2023-12-21 | Ross Cathy | director | 12,000 | A-Award | A | 12,000 | 1.25 | 15,000.00 |
| 2023-12-21 | Hare Neil E | director | 12,000 | A-Award | A | 12,000 | 1.25 | 15,000.00 |
| 2023-12-21 | Baluch Khoso | director | 12,000 | A-Award | A | 12,000 | 1.25 | 15,000.00 |
| 2023-12-21 | PFEFFER JEFFREY | director | 12,000 | A-Award | A | 12,000 | 1.25 | 15,000.00 |
| 2023-10-02 | Lehr Paul T | officer: General Counsel, Secretary | 143,398 | F-InKind | D | 815 | 2.29 | 1,866.00 |
| 2023-10-02 | Locklear Lisa | officer: Chief Financial Officer | 40,922 | F-InKind | D | 4,078 | 2.29 | 9,339.00 |
| 2023-10-02 | Agafonova Nataliya | officer: Chief Medical Officer | 23,860 | F-InKind | D | 3,059 | 2.29 | 7,005.00 |
| 2023-09-21 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | 39,191,771 | M-Exempt | D | 5,000 | 3.00 | 15,000.00 |
| 2023-09-21 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | 7,828,263 | M-Exempt | A | 5,000 | 3.00 | 15,000.00 |
| 2023-09-20 | Lehr Paul T | officer: General Counsel, Secretary | 729,625 | M-Exempt | D | 2,000 | 3.00 | 6,000.00 |
| 2023-09-20 | Lehr Paul T | officer: General Counsel, Secretary | 144,213 | M-Exempt | A | 2,000 | 3.00 | 6,000.00 |
| 2023-09-12 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | 39,196,771 | M-Exempt | D | 30,000 | 3.00 | 90,000.00 |
| 2023-09-12 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | 7,823,263 | M-Exempt | A | 30,000 | 3.00 | 90,000.00 |
| 2023-09-12 | Locklear Lisa | officer: Chief Financial Officer | 45,000 | O-OutOfTheMoney | A | 5,000 | 3.00 | 15,000.00 |
| 2023-09-12 | Locklear Lisa | officer: Chief Financial Officer | 5,000 | P-Purchase | A | 5,000 | 3.00 | 15,000.00 |
| 2023-09-12 | Locklear Lisa | officer: Chief Financial Officer | 0 | O-OutOfTheMoney | D | 5,000 | 3.00 | 15,000.00 |
| 2023-09-12 | Hashad Mohamed Wa'el Ahmed | officer: Chief Executive Officer | 95,905 | M-Exempt | D | 10,000 | 3.00 | 30,000.00 |
| 2023-09-12 | Hashad Mohamed Wa'el Ahmed | officer: Chief Executive Officer | 95,805 | S-Sale | D | 100 | 3.00 | 300.00 |
| 2023-09-12 | Hashad Mohamed Wa'el Ahmed | officer: Chief Executive Officer | 95,705 | S-Sale | D | 100 | 3.00 | 300.00 |
| 2023-09-12 | Hashad Mohamed Wa'el Ahmed | officer: Chief Executive Officer | 95,452 | S-Sale | D | 253 | 3.00 | 759.00 |
| 2023-09-12 | Hashad Mohamed Wa'el Ahmed | officer: Chief Executive Officer | 95,052 | S-Sale | D | 400 | 3.00 | 1,200.00 |
| 2023-09-12 | Hashad Mohamed Wa'el Ahmed | officer: Chief Executive Officer | 92,200 | S-Sale | D | 2,852 | 3.00 | 8,556.00 |
| 2023-09-12 | Hashad Mohamed Wa'el Ahmed | officer: Chief Executive Officer | 89,200 | S-Sale | D | 3,000 | 3.00 | 9,000.00 |
| 2023-09-12 | Hashad Mohamed Wa'el Ahmed | officer: Chief Executive Officer | 82,500 | S-Sale | D | 6,700 | 3.00 | 20,100.00 |
| 2023-09-12 | Hashad Mohamed Wa'el Ahmed | officer: Chief Executive Officer | 47,566 | M-Exempt | A | 10,000 | 3.00 | 30,000.00 |
| 2023-08-25 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | 39,531,305 | S-Sale | D | 30,000 | 3.00 | 90,000.00 |
| 2023-08-31 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | 39,506,381 | S-Sale | D | 24,924 | 3.00 | 74,772.00 |
| 2023-09-01 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | 39,309,871 | S-Sale | D | 196,510 | 3.00 | 589,530.00 |
| 2023-09-06 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | 39,292,171 | S-Sale | D | 17,700 | 3.00 | 53,100.00 |
| 2023-09-07 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | 39,276,771 | S-Sale | D | 15,400 | 3.00 | 46,200.00 |
| 2023-09-08 | Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | 39,226,771 | S-Sale | D | 50,000 | 3.00 | 150,000.00 |
| 2023-09-08 | Soffer Rock | director | 3,329,255 | M-Exempt | D | 30,000 | 3.00 | 90,000.00 |
| 2023-09-08 | Soffer Rock | director | 702,351 | M-Exempt | A | 30,000 | 3.00 | 90,000.00 |
| 2023-09-01 | Hashad Mohamed Wa'el Ahmed | officer: Chief Executive Officer | 37,566 | F-InKind | D | 4,323 | 2.64 | 11,413.00 |
| 2023-08-18 | Lehr Paul T | officer: General Counsel, Secretary | 142,213 | F-InKind | D | 767 | 3.25 | 2,493.00 |
| 2023-08-18 | Agafonova Nataliya | officer: Chief Medical Officer | 26,919 | F-InKind | D | 3,081 | 3.36 | 10,352.00 |
| 2023-08-18 | Hashad Mohamed Wa'el Ahmed | officer: Chief Executive Officer | 41,889 | F-InKind | D | 4,292 | 3.25 | 13,949.00 |
| 2023-07-31 | Locklear Lisa | officer: Chief Financial Officer | 40,000 | A-Award | A | 40,000 | 0.00 | 0.00 |
| 2023-07-31 | Locklear Lisa | officer: Chief Financial Officer | 0 | D | 0 | 0.00 | 0.00 | |
| 2023-07-24 | Agafonova Nataliya | officer: Chief Medical Officer | 30,000 | A-Award | A | 30,000 | 0.00 | 0.00 |
| 2023-04-05 | Hashad Mohamed Wa'el Ahmed | officer: Chief Executive Officer | 46,181 | F-InKind | D | 3,819 | 2.61 | 9,968.00 |
| 2023-07-01 | Agafonova Nataliya | officer: Chief Medical Officer | 0 | D | 0 | 0.00 | 0.00 | |
| 2023-06-27 | Clavijo James | officer: CFO and Treasurer | 62,303 | S-Sale | D | 8,532 | 3.48 | 29,691.00 |
| 2023-06-28 | Clavijo James | officer: CFO and Treasurer | 52,303 | S-Sale | D | 10,000 | 3.43 | 34,300.00 |
| 2023-06-29 | Clavijo James | officer: CFO and Treasurer | 47,303 | S-Sale | D | 5,000 | 3.51 | 17,550.00 |
| 2023-06-02 | Clavijo James | officer: CFO and Treasurer | 70,835 | F-InKind | D | 752 | 3.42 | 2,572.00 |
| 2023-06-09 | Baluch Khoso | director | 5,000 | A-Award | A | 5,000 | 0.00 | 0.00 |
| 2023-06-09 | PFEFFER JEFFREY | director | 5,000 | A-Award | A | 5,000 | 0.00 | 0.00 |
| 2023-06-09 | PFEFFER JEFFREY | director | 0 | D | 0 | 0.00 | 0.00 | |
| 2023-06-09 | Baluch Khoso | director | 0 | D | 0 | 0.00 | 0.00 | |
| 2023-06-02 | Lehr Paul T | officer: General Counsel, Secretary | 142,980 | F-InKind | D | 3,247 | 3.25 | 10,553.00 |
| 2023-06-02 | Clavijo James | officer: CFO and Treasurer | 71,587 | F-InKind | D | 3,247 | 3.25 | 10,553.00 |
| 2023-04-03 | Lehr Paul T | officer: General Counsel, Secretary | 146,227 | F-InKind | D | 815 | 2.61 | 2,127.00 |
| 2023-04-03 | Clavijo James | officer: CFO and Treasurer | 74,834 | F-InKind | D | 815 | 2.61 | 2,127.00 |
| 2023-03-01 | Hashad Mohamed Wa'el Ahmed | officer: Chief Executive Officer | 50,000 | A-Award | A | 50,000 | 0.00 | 0.00 |
| 2023-03-01 | Hashad Mohamed Wa'el Ahmed | officer: Chief Executive Officer | 0 | D | 0 | 0.00 | 0.00 | |
| 2023-01-27 | Hare Joshua | director: Chief Scientific Officer | 7,793,263 | S-Sale | D | 20,000 | 4.28 | 85,600.00 |
| 2023-01-03 | Lehr Paul T | director: General Counsel, Secretary | 147,042 | F-InKind | D | 1,472 | 3.37 | 4,961.00 |
| 2023-01-03 | Clavijo James | director: CFO and Treasurer | 75,649 | F-InKind | D | 1,288 | 3.37 | 4,341.00 |
| 2022-12-21 | Borger Erin | director | 5,000 | A-Award | A | 5,000 | 0.00 | 0.00 |
| 2022-12-21 | Hare Neil E | director | 5,000 | A-Award | A | 5,000 | 0.00 | 0.00 |
| 2022-12-21 | Soffer Rock | director | 5,000 | A-Award | A | 5,000 | 0.00 | 0.00 |
| 2022-12-21 | Ross Cathy | director | 5,000 | A-Award | A | 5,000 | 0.00 | 0.00 |
| 2022-12-21 | Hare Joshua | director: Chief Scientific Officer | 5,000 | A-Award | A | 5,000 | 0.00 | 0.00 |
| 2022-12-21 | LOSORDO DOUGLAS W | director | 5,000 | A-Award | A | 5,000 | 0.00 | 0.00 |
| 2022-12-21 | Ungaro Ursula | director | 5,000 | A-Award | A | 5,000 | 0.00 | 0.00 |
| 2022-12-21 | Soffer Donald M | director | 5,000 | A-Award | A | 5,000 | 0.00 | 0.00 |
| 2022-12-21 | Girolamo Todd C | director | 5,000 | A-Award | A | 5,000 | 0.00 | 0.00 |
| 2022-12-02 | Hare Joshua | director: Chief Scientific Officer | 7,813,263 | S-Sale | D | 20,000 | 3.74 | 74,800.00 |
| 2022-11-16 | Lehr Paul T | director: General Counsel, Secretary | 22,843 | A-Award | A | 22,843 | 0.00 | 0.00 |
| 2022-11-16 | Hare Joshua | director: Chief Scientific Officer | 7,861,403 | A-Award | A | 48,140 | 0.00 | 0.00 |
| 2022-10-12 | Hare Joshua | director: Chief Scientific Officer | 7,813,263 | S-Sale | D | 100,000 | 3.61 | 361,000.00 |
| 2022-10-03 | Clavijo James | director: CFO and Treasurer | 76,937 | F-InKind | D | 1,256 | 3.75 | 4,710.00 |
| 2022-10-03 | Lehr Paul T | director: General Counsel, Secretary | 148,514 | F-InKind | D | 1,435 | 3.75 | 5,381.00 |
| 2022-07-01 | Clavijo James | director: CFO and Treasurer | 78,193 | F-InKind | D | 1,426 | 5.94 | 8,470.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
